CClinicalTrials.gg
CompletedNCT04114877PARISUpdated Mar 18, 2025Results posted

Perinatal Attentional Retraining Intervention for Smoking for Minority Women

An interventional study of Attentional retraining (AR) and Visual probe (VP) in Postpartum Smoking Relapse, sponsored by Yale University. Completed at 1 site in United States. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-03-18.

Sponsored by Yale University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The proposed research intends to randomize 50 abstinent pregnant Black or Hispanic smokers to receive either the attentional retraining (AR) or control VP task. Participants will be asked to carry around a smartphone as they go about their daily lives for 2 weeks in their last month of pregnancy (Phase 1).

The smartphone will sound an alert randomly during the day, at which time participants will be asked to respond to a short set of questions assessing subjective states; this will be followed by a request to complete the AR (or control) procedures. This same procedure will be repeated for 2 weeks immediately after delivery (Phase 2).

Women will undergo a follow-up visit 3 months after the end of Phase 2, and complete an unmodified VP and follow-up assessments.

Read the detailed description

There are 2 specific aims that this study intends to address.

Specific Aim 1: To examine whether AR delivered on a smartphone can modify attentional bias to smoking-related stimuli and craving for tobacco cigarettes.

Specific Aim 2: To examine whether AR delivered on a smartphone can modify attentional bias to stress-related stimuli and reduce perceived stress.

02

Conditions studied

  • Postpartum Smoking Relapse

Browse trials for

03

In context

Recurrence

4,278 studies on the registry are indexed under Recurrence; 990 are open to participants now.

This study's enrollment of 22 is below the median of 50 across 3,373 interventional studies indexed under Recurrence.

Browse Recurrence studies →

Lead sponsor

Yale University is the lead sponsor of 1,725 studies on the registry; 299 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women with a history of smoking 5+ cigarettes per day that have achieved abstinence during pregnancy by 32 weeks gestation.
  • The ability to speak and write English.
  • An Edinburgh Postnatal Depression Scale (EPDS) score \<10.

Exclusion criteria

Exclusion Criteria:

  • Current substance abuse (e.g., alcohol, benzodiazepines, marijuana).
  • Current major depressive disorder, minor depression or dysthymia, or history of any of these disorders in the last 6 months.
  • The presence of an Axis I psychotic disorder.
  • Plans to relocate out of the area.
  • Imminent incarceration.
  • Planned inpatient hospitalization during study period.
  • Plans to breastfeed. Women who plan to breastfeed will be excluded since this is a powerful, independent motivation for remaining abstinent and may decrease the relapse event rate.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    attentional retraining (AR)

    Cognitive bias modification (CBM) procedures are interventions aimed at changing the impulsive (automatic) processes that underlie unhealthy behaviors such as smoking. Attentional retraining (AR) is the most commonly used CBM intervention in the study of addiction-related attentional bias.

    Behavioral: Attentional retraining (AR)

  • Active comparator
    visual probe (VP)

    The visual probe (VP) task can measure attentional bias for drug-related cues.

    Behavioral: Visual probe (VP)

Interventions

  • BehavioralAttentional retraining (AR)

    Cognitive bias modification (CBM) procedures are interventions aimed at changing the impulsive (automatic) processes that underlie unhealthy behaviors such as smoking. AR is the most commonly used CBM intervention in the study of addiction-related attentional bias. The idea behind AR is to reduce attentional bias and therefore minimize exposure to drug cues, because attention to such stimuli may provoke craving and undermine cessation attempts.

  • BehavioralVisual probe (VP)

    The visual probe (VP) task can measure attentional bias for drug-related cues. In the typical VP task, a pair of pictures or words (e.g. one smoking-related and one neutral) is briefly presented simultaneously side by side on a computer screen. After the pictures disappear, a probe stimulus (e.g. a small dot) is presented in the location that had been occupied by one of the pictures (or words), and participants are required to press a key as quickly as possible in response to the probe. Attentional bias for drug-related cues is detected by a faster response to a probe that replaces a drug-related stimulus (vs. a neutral stimulus), since attention will have been preferentially allocated to that area of visual display. The traditional VP task only assesses attentional bias, and does not modify it in any way.

06

What researchers measure

Primary outcomes

  1. Attentional Bias- Smoking Related Stimuli

    Attentional bias (AB) is assessed using the standard (unmodified) visual probe (VP) task on the smartphone and study visits, and measured by the reaction time (RT) in milliseconds, i.e. the time it takes a participant to identify the location of the probe after presentation of the stimulus. The AB scores will be computed as the difference in RTs on trials where the probe replaced the smoking picture vs. trials where the probe replaced the neutral picture. The VP task can measure attentional bias for drug-related cues. In the typical VP task, a pair of pictures or words (e.g. one smoking-related and one neutral) is briefly presented simultaneously side by side on a computer screen. After the pictures disappear, a probe stimulus (e.g. a small dot) is presented in the location that had been occupied by one of the pictures (or words), and participants are required to press a key as quickly as possible in response to the probe.

    Time frame: end of phase 2, up to 3 months

  2. Attentional Bias Toward Stressrelated Stimuli

    Attentional bias (AB) is assessed using the standard (unmodified) visual probe (VP) task on the smartphone and at study visits, and measured by the reaction time (RT) in milliseconds, i.e. the time it takes a participant to identify the location of the probe after presentation of the stimulus. The AB scores will be computed as the difference in RTs on trials where the probe replaced the stress-related word vs. trials where the probe replaced the neutral word. The VP task can measure attentional bias for drug-related cues. In the typical VP task, a pair of pictures or words (e.g. one smoking-related and one neutral) is briefly presented simultaneously side by side on a computer screen. After the pictures disappear, a probe stimulus (e.g. a small dot) is presented in the location that had been occupied by one of the pictures (or words), and participants are required to press a key as quickly as possible in response to the probe.

    Time frame: end of phase 2, up to 3 months

Secondary outcomes

  1. Self-reported Craving

    Self-reported craving is a single item used to assesses craving for cigarettes ("I have strong urges to smoke a cigarette") on a 7-point Likert scale (1 = Strongly Disagree, 7 = Strongly Agree) in the daily assessments delivered on the smartphone and at study visits. Higher scores on the 7-point Likert scale are indicative of higher cravings for cigarettes, with a 7 indicating high craving for a cigarette and 1 indicating low craving for a cigarette. This scale is a subjective measure of a participant's craving for cigarettes developed by the researchers and utilized in prior research.

    Time frame: end of phase 2, up to 3 months

  2. Self-reported Stress

    Self-reported stress was assessed using four items: three adapted from the Parenting Stress Index (I feel I can't handle things; I feel trapped by parenting; I feel overwhelmed by trying to meet my baby's needs) and one item developed for the study (since the last assessment my baby has been difficult to console). Participants responded to the four items on 7-point Likert-type scales (1 = Strongly Disagree, 7 = Strongly Agree) in the daily assessments delivered on the smartphone and at study visits. The mean score was computed. Higher scores on the scale are indicative of high stress levels and low scores of low stress levels.

    Time frame: end of phase 2, up to 3 months

  3. Smoking Relapse

    Relapse is defined as any smoking on 7 consecutive days or smoking at least once each week over 2 consecutive weeks. Smoking history is collected with the timeline follow-back at each study visit. This is a binary yes/no outcome. Presented here is the number of participants who relapsed to smoking.

    Time frame: from randomization to 6-month follow-up, up to 8 months

07

Results

Posted Mar 18, 2025

Participant flow

Participant flow — Overall Study
MilestoneAttentional Retraining (AR)Visual Probe (VP)
Started139
Completed139
Not completed00

Outcome measures

PrimaryAttentional Bias- Smoking Related Stimuli

Attentional bias (AB) is assessed using the standard (unmodified) visual probe (VP) task on the smartphone and study visits, and measured by the reaction time (RT) in milliseconds, i.e. the time it takes a participant to identify the location of the probe after presentation of the stimulus. The AB scores will be computed as the difference in RTs on trials where the probe replaced the smoking picture vs. trials where the probe replaced the neutral picture. The VP task can measure attentional bias for drug-related cues. In the typical VP task, a pair of pictures or words (e.g. one smoking-related and one neutral) is briefly presented simultaneously side by side on a computer screen. After the pictures disappear, a probe stimulus (e.g. a small dot) is presented in the location that had been occupied by one of the pictures (or words), and participants are required to press a key as quickly as possible in response to the probe.

Time frame:
end of phase 2, up to 3 months
Reported as:
Mean · milliseconds
Attentional Bias- Smoking Related Stimuli
millisecondsAttentional Retraining (AR)Visual Probe (VP)
Attentional Bias- Smoking Related Stimuli-44.0 ± 170.937.9 ± 163.6
Statistical analysis
  • Attentional Retraining (AR) vs Visual Probe (VP) · Mixed Models Analysis · p = >0.05Linear mixed models
PrimaryAttentional Bias Toward Stressrelated Stimuli

Attentional bias (AB) is assessed using the standard (unmodified) visual probe (VP) task on the smartphone and at study visits, and measured by the reaction time (RT) in milliseconds, i.e. the time it takes a participant to identify the location of the probe after presentation of the stimulus. The AB scores will be computed as the difference in RTs on trials where the probe replaced the stress-related word vs. trials where the probe replaced the neutral word. The VP task can measure attentional bias for drug-related cues. In the typical VP task, a pair of pictures or words (e.g. one smoking-related and one neutral) is briefly presented simultaneously side by side on a computer screen. After the pictures disappear, a probe stimulus (e.g. a small dot) is presented in the location that had been occupied by one of the pictures (or words), and participants are required to press a key as quickly as possible in response to the probe.

Time frame:
end of phase 2, up to 3 months
Reported as:
Mean · milliseconds
Attentional Bias Toward Stressrelated Stimuli
millisecondsAttentional Retraining (AR)Visual Probe (VP)
Attentional Bias Toward Stressrelated Stimuli-12.1 ± 130.6-46.5 ± 94.8
Statistical analysis
  • Attentional Retraining (AR) vs Visual Probe (VP) · Mixed Models Analysis · p = >0.05Linear mixed models
SecondarySelf-reported Craving

Self-reported craving is a single item used to assesses craving for cigarettes ("I have strong urges to smoke a cigarette") on a 7-point Likert scale (1 = Strongly Disagree, 7 = Strongly Agree) in the daily assessments delivered on the smartphone and at study visits. Higher scores on the 7-point Likert scale are indicative of higher cravings for cigarettes, with a 7 indicating high craving for a cigarette and 1 indicating low craving for a cigarette. This scale is a subjective measure of a participant's craving for cigarettes developed by the researchers and utilized in prior research.

Time frame:
end of phase 2, up to 3 months
Reported as:
Mean · score on 7-point Likert scale
Self-reported Craving
score on 7-point Likert scaleAttentional Retraining (AR)Visual Probe (VP)
Self-reported Craving1.35 ± 0.891.66 ± 1.82
Statistical analysis
  • Attentional Retraining (AR) vs Visual Probe (VP) · Mixed Models Analysis · p = >0.05Linear mixed models
SecondarySelf-reported Stress

Self-reported stress was assessed using four items: three adapted from the Parenting Stress Index (I feel I can't handle things; I feel trapped by parenting; I feel overwhelmed by trying to meet my baby's needs) and one item developed for the study (since the last assessment my baby has been difficult to console). Participants responded to the four items on 7-point Likert-type scales (1 = Strongly Disagree, 7 = Strongly Agree) in the daily assessments delivered on the smartphone and at study visits. The mean score was computed. Higher scores on the scale are indicative of high stress levels and low scores of low stress levels.

Time frame:
end of phase 2, up to 3 months
Reported as:
Mean · score on a scale
Self-reported Stress
score on a scaleAttentional Retraining (AR)Visual Probe (VP)
Self-reported Stress3.34 ± 0.773.57 ± 0.70
Statistical analysis
  • Attentional Retraining (AR) vs Visual Probe (VP) · Mixed Models Analysis · p = >0.05Linear mixed models
SecondarySmoking Relapse

Relapse is defined as any smoking on 7 consecutive days or smoking at least once each week over 2 consecutive weeks. Smoking history is collected with the timeline follow-back at each study visit. This is a binary yes/no outcome. Presented here is the number of participants who relapsed to smoking.

Time frame:
from randomization to 6-month follow-up, up to 8 months
Reported as:
Count of participants · Participants
Smoking Relapse
ParticipantsAttentional Retraining (AR)Visual Probe (VP)
Smoking Relapse42
Statistical analysis
  • Attentional Retraining (AR) vs Visual Probe (VP) · Fisher Exact · p = 0.455

Adverse events

Collected over 8 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Attentional Retraining (AR)0/13 (0%)0/13 (0%)0/13 (0%)
Visual Probe (VP)0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
>30 years10414
≤30 years358
Sex: Female, Male
Sex: Female, Male(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
Female13922
Male000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
Hispanic, White213
Hispanic, Black314
Black, non-Hispanic8614
>1 Race, non-Hispanic011
Region of Enrollment
Region of Enrollment(participants)Attentional Retraining (AR)Visual Probe (VP)Total
United States13922
Education
Education(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
< High school degree123
High school degree527
Some college (no degree)5510
Associate's degree101
Refuse to Answer101
Pre-quit smoking level
Pre-quit smoking level(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
≤10 cigarettes/day11516
>10 cigarettes/day246
Anxiety
Anxiety(Participants)Attentional Retraining (AR)Visual Probe (VP)Total
Yes459
No9413
Age started smoking (years)
Age started smoking (years)(years)Attentional Retraining (AR)Visual Probe (VP)Total
Mean15.8 ± 3.215.9 ± 1.515.8 ± 2.6
08

Study locations

1 site
  • Yale University
    New Haven, Connecticut 06510, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Nov 2, 2023
  • Informed consent form · Nov 2, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04114877
Lead sponsor
Yale University
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Sponsor
First posted
Oct 3, 2019
Start date
Nov 18, 2020
Primary completion
Dec 1, 2023
Completion
Dec 1, 2023
Results posted
Mar 18, 2025
Last update
Mar 18, 2025

Study contacts

Ariadna Forray, MD
principal investigator · Associate Professor of Psychiatry; Psychiatry Director, Adult Sickle Cell Program; Co-Director, Center for Wellbeing of Women and Mothers

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion